Innoviva, Inc.INVANASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank57
3Y CAGR-1.1%
5Y CAGR-4.0%
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

3Y CAGR
-1.1%/yr
vs -0.5%/yr prior
5Y CAGR
-4.0%/yr
Consistent
Acceleration
-0.6pp
Decelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM90.02%+277.7%
202423.84%-68.5%
202375.71%-18.6%
202293.05%-21.5%
2021118.50%+7.1%
2020110.62%+11.0%
201999.70%+4.9%
201895.05%+7.6%
201788.33%-6.3%
201694.26%-